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Background: The ability of different obesity indices to predict cardiovascular risk is still debated in youth and few
data are available in sub Saharan Africa. We compared the associations between several indices of obesity and
cardiovascular risk factors (CVRFs) in late adolescence in the Seychelles.
Methods: We measured body mass index (BMI), waist circumference, waist/hip ratio (WHiR), waist/height ratio
(WHtR) and percent fat mass (by bioimpedance) and 6 CVRFs (blood pressure, LDL-cholesterol, HDL-cholesterol,
triglycerides, fasting blood glucose and uric acid) in 423 youths aged 19–20 years from the general population.
Results: The prevalence of overweight/obesity and several CVRFs was high, with substantial sex differences. Except
for glucose in males and LDL-cholesterol in females, all obesity indices were associated with CVRFs. BMI consistently
predicted CVRFs at least as well as the other indices. Linear regression on BMI had standardized regression
coefficients of 0.25-0.36 for most CVRFs (p<0.01) and ROC analysis had an AUC between 60%-75% for most CVRFs.
BMI also predicted well various combinations of CVRFs: 36% of male and 16% of female lean subjects (BMI <P50)
had ≥2 CVRFs compared to 74% of male and 46% of female overweight subjects (BMI >P90).
Conclusion: There was an elevated prevalence of obesity and of several CVRFs in youths in Seychelles. BMI
predicted single or combined CVRFs at least as well as other simple obesity indices.
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AfricaBackground
Obesity in youth has important short term and long
term impact on health [1], including increased cardio-
vascular mortality and morbidity in middle age [2-4].
The detrimental impact of obesity on the incidence of
subsequent cardiovascular disease (CVD) is partly
mediated by increased levels of cardiovascular risk fac-
tors (CVRF), in particular hypertension, dyslipidemia
and diabetes [4].
The comparative value of different indices of obesity
for the prediction of cardiovascular outcomes is still
debated. This question is differently framed whether the* Correspondence: pascal.bovet@chuv.ch
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reproduction in any medium, provided the oremphasis is to predict: i) the actual adiposity status,
which relies on the comparison of indices of obesity with
objective measurements of general/central fat, ii) subse-
quent cardiovascular outcomes, which relies on cohort
studies [2,4], or iii) the presence of concomitant CVRFs
[5,6], which can be assessed with cross-sectional studies.
In this paper, the focus is on the performance of indices
of obesity to predict the presence of concomitant CVRFs
in young adults.
Several studies and reviews have examined the per-
formance of different obesity indices to predict the con-
comitant presence of abnormal levels of CVRF in youths
including high blood pressure, dyslipidemia and diabetes
[5]. BMI, which is a simple and widely used metric, has
been criticized as an inadequate measure of obesity
because it does not distinguish well between lean mass
and fat mass. Other advocated indices include waisttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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waist-to-height ratio (WHtR) [10,11] or percent body fat
based on bioimpedance [12]. Mixed results have been
reported, but several studies and reviews have concluded
that BMI performed as well as other obesity indices for
the identification of an adverse cardiometabolic risk pro-
file in youths [13-15].
The performance of anthropometric indices may vary
according to various factors, including race, geographical
area, and population [16]. However, few studies have
examined the performance of anthropometric indices for
the identification of adverse cardiovascular risk profiles
in sub Saharan Africa populations [17-19], and none
among representative samples of youths. A challenge for
such studies is the need to collect biological samples (e.g.
blood lipids) from healthy young individuals. It is import-
ant to collect information on the associations between
obesity indices and CVRFs in African populations to
guide recommendations for surveillance and clinical
practice in the region, particularly in the context of the
rapidly rising prevalence of obesity worldwide, including
in the Seychelles [20].
In this study, we examined the associations between
several obesity indices and the main CVRFs in a
population-based sample of late adolescents of the Sey-
chelles aged 19–20 years. Seychelles is a middle-income
country in the African region. The study also provides
useful information on the prevalence of the major
CVRFs in youths in this region.
Methods and Procedures
Subjects
The Republic of Seychelles is a small island state in the
Indian Ocean located east of Kenya. The majority of the
population is of African descent.
Between February 1989 and February 1990, a cohort of
779 children was enrolled at the age of 6 months as part
of the Seychelles Child Development Study. This on-
going cohort study was undertaken to examine the asso-
ciation between exposure to methyl mercury from fish
consumption and the children’s neurological outcomes.
The study methodology was previously described [21].
Study participants were evaluated in 2008 and 2009 at
age 19–20 years. Cardiovascular outcomes were evalu-
ated including neurovegetative and cardiometabolic
ones. Informed written consent for participation was
obtained from all participants. The protocol was
approved by the institutional review boards of the Uni-
versity of Rochester Medical Center and the Republic of
Seychelles.
Evaluation
Anthropometric data were measured without shoes and in
light garments. Weight was measured using a precisionelectronic scale (Seca 870, Hamburg, Germany) and
height was measured with a fixed stadiometer (Seca 208).
Body mass index (BMI) was calculated as weight (kg)
divided by height (meters) squared. Waist circumference
was measured at mid distance between the floating rib
and the iliac crest at the end of normal expiration with a
standard tape measure. Hip circumference was measured
to the nearest 0.1 cm at the point of maximum extension
of the buttocks. Body fat percent was assessed using a
bioimpedance analyzer (Omron HBF-306C). All an-
thropometric indices were measured once. Blood pres-
sure (BP) was based on the average of three readings
taken on the left arm with a validated oscillometric auto-
mated device (Omron M5, Omron Healthcare Europe
BV, Hoofddorp, The Netherlands) using an appropriately
sized cuff, after a 5 minute rest. Three senior nurses with
experience in conducting epidemiological research per-
formed the measurements. When comparing mean
values of the measurements in participants between the
observers’ groups, adjusting for sex and age, there was no
difference between for height, weight, waist, WHiR, BMI,
fat percent and systolic/diastolic BP, but a statistically sig-
nificant difference was found for hip and WHtR. This
suggests lower validity of measurements involving hip. A
structured questionnaire was self-administered to assess
alcohol consumption and smoking status. Tobacco use
and alcohol use were assessed with the questions: “Dur-
ing the past 30 days, on how many days did you [smoke
at least on cigarette] [have at least one drink]?” with
answers to chose among categories: 0 day; 1–2 days;
3–5 days; 6–9 days; 10–19 days; 20–29 days; and every
day. Smoking was defined for participants reporting to
smoke at least one cigarette every day. Physical activity
was assessed using the Global Physical Activity Ques-
tionnaire (GPAQ) [22].
Biological sampling
A venous blood sample was collected between 7 and 9
am after an overnight fast. Glucose, total cholesterol,
HDL-cholesterol, triglycerides and uric acid were mea-
sured at the central laboratory of the main hospital in
the Seychelles (Victoria Hospital), using standard en-
zymatic methods (Konelab T series reagents, Thermo
Scientific) with a Thermo Konelab 30 automatic analyzer
(Konelab Corp., Espoo, Finland). LDL-cholesterol was
calculated with the Friedewald formula.
Statistical analyses
We conducted analyses separately in males and females
because of substantially different distributions of several
variables. Since the aim of the study is the prediction of
the presence of concomitant CVRFs according to various
indices of obesity, main analyses are not adjusted for
other covariates. We first examined the association
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ous scales using linear regression. We display the stan-
dardized regression coefficients, which express a
difference in the “outcome” variable corresponding to a
difference of 1 standard deviation in the “exposure” vari-
able. This permits direct comparison of the regression
coefficients between different obesity indexes and across
the different CVRFs. We then estimated the prevalence
of elevated levels of CVRFs according to increasing
categories of obesity indices. We categorized all obesity
indices in five categories (i.e. percentiles <50, 50–79,
80–89 and 90–100). We performed ROC (Roc Operat-
ing Characteristics) analysis [23] to evaluate the per-
formance of the indices of obesity: the area under the
curve (AUC) statistic represents the probability of cor-
rectly identifying subjects with or without the outcome
of interest (i.e. CVRFs). An AUC of 0.5 means that
prediction is not better than chance and 1.0 represents
perfect discrimination. We defined dichotomized categor-
ies of CVRFs based on recent guidelines for subjects aged
18–21 [24]. Because only 4% of subjects had triglycerides
≥1.3 mmol/l, we used a lower cutoff (≥1.0 mmol/l), whichTable 1 Distribution of obesity indices and cardiovascular risk
Males (n=195)
Anthropometric variables
Height (cm) 175.0
Weight (kg) 66.2 1
Body mass index (kg/m2) 21.6
≥ 25 13.3
≥ 30 4.6
Waist (cm) 75.9
≥ 94 (M); ≥80 (F) 5.6
≥102 (M); ≥88 (F) 2.1
Waist/height ratio 43.3
≥0.50 9.7
Waist/hip ratio 0.83 0
Fat percent 16.8
Cardiovascular risk factors
Daily cigarette smoking 20.0
Alcohol on ≥6 days/month 19.5
Physical activity >3000 MET-min/wk 64.4
Systolic blood pressure (mmHg) 121.2 1
Diastolic blood pressure (mmHg) 67.0
Total cholesterol (mmol/l) 4.06 0
LDL-cholesterol (mmol/l) 2.28 0
HDL-cholesterol (mmol/l) 1.46 0
Triglycerides (mmol/l) 0.69 0
Glucose (mmol/l) 5.24 0
Uric acid (mmol/l) 0.33 0
P values are indicated in italic.resulted in a prevalence of 12%. There is no widely used
cutoff for serum uric acid in youth and we defined ele-
vated levels as above the sex-specific 80th percentile.
Finally, we examined the prevalence of combinations of
the 6 considered CVRFs across categories of the obesity
indices. Analyses were performed using Stata 11.2. We
used two-sided tests and considered statistical signifi-
cance as P <0.05.
Results
The distribution of the obesity indices and the CVRFs is
shown in Table 1. Males were taller and heavier than
females but BMI was higher in females than in males
(27% of females and 13% of males had BMI ≥25 kg/m2).
Waist circumference was similar in both sexes but the
proportion with elevated waist circumference was higher
in females than in males. While the waist/hip ratio
(WHiR) was larger in males than in males, the waist/
height (WHtR) ratio and the percentage of body fat were
larger in females than in males. There were marked dif-
ferences in the distribution of CVRFs according to sex.
Males smoked more, consumed more alcohol, and hadfactors
Females (n=228) P
6.8 162.5 6.7 0.000
2.2 59.8 14.6 0.000
3.6 22.7 3.3 0.016
26.7 0.000
10.5 0.000
8.6 75.7 11.2 ns
28.5 0.000
14.9 0.000
3.5 46.6 4.6 0.000
26.7 0.000
.07 0.82 0.09 0.017
6.7 26.8 7.9 0.000
3.1 0.000
5.7 0.000
18.4 0.000
1.2 110.5 10.0 0.000
8.1 69.1 8.0 0.008
.81 4.23 0.86 0.031
.74 2.56 0.81 0.000
.43 1.36 0.39 0.011
.28 0.69 0.28 ns
.58 4.96 0.58 0.000
.08 0.24 0.70 0.000
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BP but not diastolic BP was markedly higher in males
than in females. Males had higher LDL-cholesterol and
lower HDL-cholesterol levels than females, but mean tri-
glyceride levels were similar in both sexes. Mean levels
of blood glucose and uric acid were higher in males than
in females.
BMI, waist and WHtR correlated highly with each
other (correlation coefficient ~0.9, p< 0.001) in both
males and females. These three indices also correlated
highly with body fat mass in females (0.84-0.90) but less
strongly in males (~0.7). The correlation coefficients
with WHiR were markedly lower (<0.5), but still highly
significant (p<0.001).
The prevalence of CVRFs increased in a dose response
manner across increasing categories of all obesity indices
except for HDL-cholesterol (males and females) and
blood glucose (males) (Table 2). Associations were weakest
for WHiR. For most of the associations, the prevalence
increased by an order of 50%-300% when comparing a
CVRF between low (<P50) vs. high (>P90) categories of
the obesity indices. The associations with the CVRFs were
generally strong with BMI.
Based on continuous variables (linear regression), all
obesity indices except WHiR were associated with all
CVRFs, except for LDL-cholesterol in females and blood
glucose in males (Table 3). The regression coefficients
were high for BMI in most instances, although the asso-
ciations with BMI were not markedly different than the
associations with waist, WHtR (particularly in males)
and body fat mass for several CVRFs. The standardized
regression coefficients (range from 0 to 1) relating BMI
and CVRFs were fairly high, e.g. 0.25-0.36 for BP, 0.26-
0.40 for triglycerides, 0.37 for blood glucose (females),
and 0.27-0.34 for uric acid. Associations were weaker for
HDL-cholesterol in both sexes (e.g. 0.17-0.21 for BMI).
The associations between the obesity indices and CVRFs
were virtually unchanged when adjusting for smoking,
alcohol intake, and physical activity (results not shown).
In ROC analysis (Table 4), the AUC ranged consist-
ently between 60% and 70% for the probability that the
indices of obesity correctly identified subjects with
CVRFs, except for individuals with low HDL-cholesterol
(females) and high blood glucose (males). The highest
AUC was observed for triglycerides (e.g. 75% for BMI
among males and consistently >70% for several other
indices had elevated triglycerides). Overall, BMI per-
formed well in predicting individuals with CVRFs.
The mean number of CVRFs (range: 0–6) and the
prevalence of combinations of CVRFs according to cat-
egories of the different obesity indices is shown in
Table 5. The proportion of youth with several CVRFs
increased markedly along increasing categories of obesity
for all obesity indices. Of note, the displayed valuescorrespond to the predictive positive value for the test
set at the mentioned BMI levels (e.g. there is a 73.7%
probability that a male with a BMI ≥P90 has ≥2 CVRFs).
We calculated that to predict the presence of
≥2CVRFs among male/female youth, a BMI cutoff set at
≥P80 had a sensitivity of 28%/37%, a specificity of 86%/
87%, a positive predictive value of 62%/53% and a nega-
tive predictive value of 60%/78%. The positive predictive
value of such a test to detect ≥2 CVRFs (62%/53%) was
only slightly larger than the a priori chance to classify
individuals with ≥2 CVRFs in the population, which
equates to the overall prevalence of individuals in the
population with ≥2 CVRFs, i.e. 44% of males and 28%
of females (Table 5). The sensitivity of this test is low
because the large majority of individuals with ≥2
CVRFs are found among the 80% of persons with BMI
<P80.
Discussion
We found a high prevalence of several CVRFs, including
obesity, in late adolescents in the Seychelles, with
marked differences between males and females. All the
obesity markers studied were strongly associated with
most of the CVRFs, except for WHiR. BMI performed at
least as well as the other indices for the prediction of
single or combined CVRFs, with a few exceptions.
The high prevalence of CVRFs, including obesity, in
youths in Seychelles is consistent with findings from
other surveys in children [20] and in adults [25] in Sey-
chelles. A high prevalence of several CVRFs, particularly
obesity, is increasingly well documented in adults in Af-
rica [26]. This study contributes new information on the
prevalence of CVRFs in youth, an age category where
limited data are available in the region, particularly with
regards to biological markers such as blood lipids and
uric acid. Our finding of a high prevalence of CVRFs in
youths reiterates the importance of a life course approach
for prevention and control of cardiovascular disease [26].
The distribution of several CVRFs differed markedly
according to sex in this study. This finding may relate to
differences in body composition, e.g. higher fat mass
among females and higher muscular mass among males.
We found higher systolic BP and higher blood glucose
in males than females, but similar levels of triglycerides.
We also found lower LDL-cholesterol in males than in
females which is consistent with studies of youth in
other countries [27]. The sex difference in systolic BP
may relate to the large height difference between males
and females, since height is an important driver of BP in
youth [28]. Although recent guidelines consider same
cutoffs for males and females at age 18–21 [24], sex-
specific cutoffs could be more appropriate at the transi-
tion between adolescence and adulthood in view of the
twofold higher prevalence of elevated BP in male than
Table 2 Prevalence of risk factors according to categories of different obesity indices
Males Females
BMI Waist WHiR WHtR Fat% BMI Waist WHiR WHtR Fat%
Blood pressure ≥120/80 mmHg (M: 52.3%; F: 21.9%)*
P <50 39.7 40.6 49.5 41.2 43.3 10.5 9.1 22.8 14.9 9.6
P 50-79 62.6 58.3 45.7 57.6 59.3 30.4 36.7 22.1 24.6 31.9
P 80-89 75.0 75.0 72.2 75.0 60.0 39.1 25.9 26.0 34.8 40.9
P 90+ 63.1 68.4 68.4 68.4 68.4 36.4 34.7 13.0 36.4 34.7
0.004 0.007 ns 0.009 0.080 0.000 0.000 ns 0.037 0.000
LDL-cholesterol ≥3.0 mmol/l (M: 10.8%; F: 29.0%)
P <50 3.1 5.2 6.1 6.2 9.3 23.7 27.3 28.1 25.4 23,7
P 50-79 15.5 11.7 15.2 8.5 10.2 27.5 26.4 26.4 27.5 27.5
P 80-89 15.0 20.0 11.1 25.0 15.0 56.5 33.3 34.7 43.5 45.4
P 90+ 31.6 26.3 21.1 26.3 15.8 31.8 39.1 34.7 36.4 43.5
0.004 0.021 ns 0.010 ns 0.017 ns ns ns 0.076
HDL-cholesterol <1.03 mmol/l (M: 14.4%; F: 19.3%)
P <50 8.1 11.4 17.2 10.3 8.2 16.7 13.6 14.9 13.2 18.4
P 50-79 20.7 15.0 11.9 16.9 20.3 23.2 25.0 20.5 29.0 20.2
P 80-89 10.0 15.0 11.0 10.0 20.0 30.4 30.9 30.4 26.1 27.3
P 90+ 31.6 26.3 10.5 31.6 21.0 10.0 17.3 26.1 13.6 13.0
ns ns ns ns ns ns ns 0.018 ns Ns
Triglycerides ≥1.00 mmol/l (M: 10.3%; F: 12.7%)
P <50 5.1 6.5 6.1 7.2 7.2 5.2 4.5 12.3 4.3 7.0
P 50-79 8.6 6.7 8.5 3.4 5.1 15.9 16.1 10.3 15.9 10.1
P 80-89 20.0 25.0 16.7 20.0 20.0 21.7 18.5 21.7 21.7 27.3
P 90+ 31.6 26.3 31.6 36.8 31.6 31.8 34.8 13.0 36.4 34.8
0.002 0.006 0.006 0.000 0.003 0.002 0.000 ns 0.000 0.000
Glycemia ≥5.6 mmol/l (M: 23.1%; F: 8.8%)
P <50 24.5 26.0 23.2 24.7 21.6 5.3 5.4 7.0 6.1 3.5
P 50-79 24.1 20.0 22.0 20.3 28.8 4.3 5.8 10.3 4.3 7.2
P 80-89 10.0 15.0 27.8 30.0 25.0 17.3 14.8 13.0 13.0 27.3
P 90+ 26.3 26.3 21.0 15.7 10.5 31.8 26.0 8.8 31.8 21.7
ns ns ns ns ns 0.000 0.007 ns 0.000 0.000
Uric acid >0.39 (M) or > 0.31 (F) μg/l (M: 20%; F: 20%)
P <50 14.3 11.4 14.1 13.4 13.4 14.9 15.5 20.2 16.7 15.8
P 50-79 15.5 21.7 30.5 20.3 20.3 23.2 20.5 16.2 18.8 17.4
P 80-89 20.0 25.0 5.5 20 25.0 17.3 22.2 30.4 17.3 31.8
P 90+ 52.6 42.0 21.0 42.1 36.8 40.9 39.1 21.7 45.4 39.1
0.001 0.012 ns 0.034 ns 0.04 ns ns 0.02 0.034
* The overall prevalence of cardiovascular risk factors (CVRFs) is displayed between parentheses for males (M) and females (F).
BMI: body mass index; WHiR; waist/hip ratio; WHtR: waist/height ratio; Fat%: percent body fat (bioimpedance).
P values are indicated in italic.
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obesity in females than in males. The higher levels of
glucose in males than in females, despite higher levels of
obesity (a marker for increased insulin resistance) in
males could be partly related to a poorer fasting state
among males. It is also compatible with fasting blood
glucose being a poor marker of insulin resistance [29].
Higher levels of HDL-cholesterol in males than infemales in our study is consistent with results reported
in adults in Seychelles [25], but it contrasts with higher
levels of HDL-cholesterol in females than in males in
several other populations [30]. Serum triglycerides level
was low in young adults of Seychelles which is consist-
ent with a trend toward lower triglycerides values in
blacks than in whites [31]. It is not yet clear whether
uric acid is an independent CVRF, but strong evidence
Table 3 Standardized linear regression coefficients for the association between obesity indices and cardiovascular risk
factors
Males Females
BMI Waist WHiR WHtR Fat% BMI Waist WHiR WHtR Fat%
Systolic BP 0.25*** 0.25*** 0.09ns 0.23** 0.19** 0.30*** 0.29*** 0.12ns 0.23*** 0.34***
Diastolic BP 0.25*** 0.24*** 0.10ns 0.25** 0.15* 0.36*** 0.32*** 0.10ns 0.29*** 0.40***
LDL-cholesterol 0.24** 0.19* 0.16* 0.23** 0.17* 0.06ns 0.04ns 0.00ns 0.08ns 0.12*
HDL-cholesterol −0.21** −0.12ns 0.00ns −0.15* −0.16* −0.17** −0.19** −0.17* −0.22** −0.14*
Triglycerides 0.40*** 0.37*** 0.20** 0.41*** 0.29*** 0.26*** 0.29*** 0.08ns 0.31*** 0.26***
Fasting glucose 0.05ns 0.03Ns 0.06ns 0.07ns 0.06ns 0.37*** 0.36*** 0.21** 0.36*** 0.25***
Uric acid 0.34*** 0.35*** 0.23** 0.37*** 0.27*** 0.27*** 0.30*** 0.15* 0.30*** 0.25***
BMI: body mass index; WHiR; waist/hip ratio; WHtR: waist/height ratio; Fat%: fat percent (bioimpedance).
Each line represents a different model, separately in males and in females.
* p<0.05; ** p <0.01; *** p <0.001.
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hypertension. This association is particularly strong in
younger individuals [32]. Serum uric acid concentration
is higher in males than in females in all populations,
which may relate to higher muscular metabolic turnover.
These substantial sex differences in the distribution of
several CVRFs among late adolescents emphasize the
importance of conducting epidemiological studies in
different populations among all age groups.
All indices of obesity, except WHiR, were strongly
associated with most of the considered CVRFs. These
findings concur with studies in youth in Western coun-
tries [6,14]. Lower performance with WHiR can relate to
the larger likelihood for random variation and/or bias in
the measurements of both waist and hip, and perhaps
particularly for hip (as we found in our data), compared
to easier and more standardized measurements of
height, weight and the related indices. These associations
were of similar magnitude whether the obesity indicesTable 4 AUC values for obesity indices for the prediction of e
Males
BMI Waist WHiR WHtR Fat% BM
BP ≥120/90 66.1 67.2 58.1 64.7 61.3 69.8
58-73 60-75 50-66 57-72 53-69 62-7
LDL-cholesterol ≥3.0 72.5 70.9 67.1 68.5 62.9 58.9
61-84 60-82 55-79 56-81 50-75 51-6
HDL-cholesterol <1.0 62.6 54.9 48.1 58.7 62.5 55.5
51-73 43-61 41-58 45-63 52-73 47-6
Triglycerides ≥1.0 74.6 70.1 72.0 69.7 67.8 71.1
64-86 57-83 60-83 55-84 54-82 60-8
Glycemia ≥ 5.6 48.9 45.8 50.9 50.9 50.0 72.5
39-59 36-55 42-60 41-60 41-59 61-8
Uric acid ≥P80 63.9 65.7 57.3 64.8 63.0 58.6
53-74 56-76 48-67 55-74 52-73 48-6
AUC: area under the receiver operator characteristics (ROC) curve.
BMI: body mass index; WHiR: waist/ratio; WHtR: waist/height ratio; Fat%: fat percentwere intended to assess central fat mass (waist, WHtR)
or overall fat mass (BMI, percent fat) and whether the
CVRFs were essentially vascular (BP) or metabolic
(blood lipids, glycemia). Overall, BMI performed as well
as the other obesity indices for the prediction of CVRFs.
The findings are robust since we found similar findings
whether the analyses were based on categorical variables
(which do not assume a dose response relationship) or
continuous variables (which assume a dose response
relationship). The good performance of BMI compared
to other obesity indices like waist circumference or
WHtR is not surprising in view of the high correlation
between the indices we studied. Bouchard noted that
all simple obesity indices (e.g. BMI, fat mass, and
waist) provide essentially similar information because
they correlate equally well both with each other (r >0.90)
and with CT-scan measured abdominal visceral fat, but
less well (~0.7-0.8). Most of the variance of obesity-
related anthropometrics is captured by BMI, and all theselevated cardiovascular risk factors
Females Indices with highest AUC
I Waist WHiR WHtR Fat% Males Females
69.4 53.8 66.1 69.7 W, BMI, WHtR BMI, F%, W
7 62-77 46-62 58-74 62-77
56.1 52.9 56.9 58.6 BMI, W BMI, F%
7 48-64 44-61 49-65 50-67
56.9 56.7 59.5 50.3 BMI, F% WHtR, WHiR
3 48-64 50-67 51-68 43-59
73.2 57.4 73.2 70.2 BMI, WHiR, W WHt, W, BMI
2 64-83 47-67 63-83 59-81
71.2 58.6 69.8 74.3 - F%, BMI, W
5 58-84 46-72 57-83 63-85
60.1 53.8 61.5 59.9 W, WHtR, BMI WHtR, W, F%
8 50-70 44-63 52-71 50-70
.
Table 5 Mean score of cardiovascular risk factors (CVRF) and proportions with ≥2 CVRFs and ≥3 CVRFs according to
categories of obesity indices
Males Females
BMI Waist WHiR WHtR Fat% BMI Waist WHiR WHtR Fat%
Mean score
P <50 1.13 1.15 1.31 1.40 1.19 0.67 0.64 0.91 0.68 0.68
P 50-79 1.59 1.53 1.46 1.49 1.68 1.06 1.14 0.96 1.07 1.01
P 80-89 1.75 1.95 1.78 2.10 1.70 1.73 1.33 1.26 1.43 1.73
P 90+ 2.47 2.26 1.95 2.32 1.95 1.50 1.60 1.00 1.68 1.61
0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.003 0.000 0.000
Score ≥ 2CVRFs (M: 44.1%, F: 28.1%)
P <50 35.7 35.4 39.4 34.0 36.1 15.8 15.4 27.2 16.7 1.7
P 50-79 46.5 46.7 45.8 45.7 54.2 31.9 36.8 30.9 31.9 31.9
P 80-89 50.0 55.0 55.6 65.0 45.0 60.9 44.4 34.7 52.2 54.5
P 90+ 73.7 68.4 52.6 68.4 52.6 45.5 43.5 17.4 50.0 47.8
0.019 0.035 ns 0.007 ns 0.000 0.001 ns 0.000 0.000
Score ≥ 3CVRFs (M: 14.9%, F: 7.0%)
P <50 6.1 8.3 11.1 7.2 6.1 0.0 0.0 7.9 0.0 0.0
P 50-79 19.0 13.3 13.5 11.9 22.0 8.9 8.8 4.4 8.7 8.7
P 80-89 20.0 30.0 27.8 45.0 25.0 17.3 14.8 8.7 13.0 18.0
P 90+ 42.1 36.8 26.3 31.6 26.3 27.3 26.1 8.7 31.8 26.0
0.000 0.003 ns 0.000 0.008 0.000 0.000 ns 0.000 0.001
Score ranges between 0–6 according to the presence of 6 CVRFs: BP ≥120/80 mmHg; LDL-cholesterol ≥3 mmol/l; HDL <1.03 mmol/l; triglycerides ≥1.0 mmol/l;
glucose ≥5.6 mmol/l; uric acid > sex-specific percentile 80.
P values are indicated in italic.
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Furthermore, total fat mass and muscular mass (perhaps
better captured by BMI) can be just as important as vis-
ceral fat mass (perhaps better captured by waist circum-
ference) when predicting the presence of concomitant
CVRFs. Of note, sex differences in the ability of the obes-
ity indices to predict some CVRFs emphasize the need to
analyze associations between obesity indices and CVRFs,
and their related discriminating power to predict CVRFs,
by sex in this young age range.
Despite fairly strong associations, the obesity indices
had limited ability to predict CVRFs. For example, a
male youth had a 74% chance to have ≥2 CVRFs if he
was overweight (BMI >P90) but as much as 36% if he
was lean (BMI <P50) (Table 5). This translated into a
poor sensitivity: a test using BMI above percentile 80
would miss most individuals with ≥2 CVRFs in the
population. These findings are consistent with the fact
that any measured characteristic must be very tightly
associated with an outcome to be a good screening tool
[34]. The US Preventive Services Task Force has recom-
mended that children and adolescents are screened for
obesity using BMI. This follows from the strong associ-
ation of BMI with body fat and the availability of effect-
ive interventions for weight control at the individual
level in youth [35]. The potential use of obesity indices
to screen for the presence of CVRFs in youths is,however, a distinct issue. Because they are simple, reli-
able and inexpensive metrics, one should evaluate
whether obesity indices, and particularly BMI, could be
used as filters in stepwise strategies for the identifica-
tion of CVRFs [36]. This might be particularly helpful
in low resources settings.
Strengths of the study include the population-based de-
sign, the fairly large sample size considering its reliance
on blood samples in healthy young individuals, and the
availability of a broad panel of CVRFs. The study also has
some limitations. We cannot be sure that participants
were fasting, which may weaken associations with bio-
logical markers. We took only one measurement of the
anthropometric indices, and we did not assess differences
in measurements between the observers during the
study. However, all our observers had long experience
with epidemiological research. Furthermore, the goal of
the study was to examine the performance of adiposity
indices to predict the presence of concomitant CVRFs: it
is likely that these conditions (one single measurement
for the adiposity indices and good but perhaps not opti-
mal skills of the observers for these measurements) cor-
respond to a situation commonly found in clinical
practice. The sample size was not adequate for precise
analysis among extreme categories of overweight [6]. Of
note, the cross-sectional design is not a limitation when
predicting CVRFs from current indices of obesity.
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In conclusion, we found an increased prevalence of obes-
ity and CVRFs in late adolescence in the Seychelles. We
also found that BMI performed generally at least as well
as the other obesity indices to predict the presence of
single or combined CVRFs at this young age in this
population. These findings highlight the broad metabolic
derangements of obesity in youth and the subsequent
need for appropriate weight control interventions at the
individual and population levels. Further epidemiological
studies should evaluate whether obesity indices could be
combined with other markers to provide efficient screen-
ing tests of cardiovascular risk in youths and young
adults.
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